232 related articles for article (PubMed ID: 14582698)
1. Safety and growth suppressive effect of intra-hepatic arterial injection of AdCMV-p53 combined with CDDP to rat liver metastatic tumors.
Okimoto T; Yahata H; Itou H; Shinozaki K; Tanji H; Sakaguchi T; Asahara T
J Exp Clin Cancer Res; 2003 Sep; 22(3):399-406. PubMed ID: 14582698
[TBL] [Abstract][Full Text] [Related]
2. In vivo studies of adenovirus-mediated p53 gene therapy for cis-platinum-resistant human ovarian tumor xenografts.
Song K; Cowan KH; Sinha BK
Oncol Res; 1999; 11(3):153-9. PubMed ID: 10527075
[TBL] [Abstract][Full Text] [Related]
3. p53 gene therapy in a rat model of hepatocellular carcinoma: intra-arterial delivery of a recombinant adenovirus.
Anderson SC; Johnson DE; Harris MP; Engler H; Hancock W; Huang WM; Wills KN; Gregory RJ; Sutjipto S; Wen SF; Lofgren S; Shepard HM; Maneval DC
Clin Cancer Res; 1998 Jul; 4(7):1649-59. PubMed ID: 9676839
[TBL] [Abstract][Full Text] [Related]
4. Intra-arterial delivery of a recombinant adenovirus does not increase gene transfer to tumor cells in a rat model of metastatic colorectal carcinoma.
Maron DJ; Tada H; Moscioni AD; Tazelaar J; Fraker DL; Wilson JM; Spitz FR
Mol Ther; 2001 Jul; 4(1):29-35. PubMed ID: 11472103
[TBL] [Abstract][Full Text] [Related]
5. Ki-ras codon 12 point and P53 mutations: a molecular examination of the main tumor, liver, portal vein, peripheral arterial blood and para-aortic lymph node in pancreatic cancer.
Yamaguchi K; Chijiiwa K; Torato N; Kinoshita M; Tanaka M
Am J Gastroenterol; 2000 Aug; 95(8):1939-45. PubMed ID: 10950039
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated gene transfer of P16INK4/CDKN2 into bax-negative colon cancer cells induces apoptosis and tumor regression in vivo.
Tamm I; Schumacher A; Karawajew L; Ruppert V; Arnold W; Nüssler AK; Neuhaus P; Dörken B; Wolff G
Cancer Gene Ther; 2002 Aug; 9(8):641-50. PubMed ID: 12136424
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of mouse liver metastasis by intraportal injection of Adv-p53].
Su W; Zhang JH; Liu HW; Xiao G; Zhou XP; Sun JH; Liao CJ; Huang MX
Zhonghua Zhong Liu Za Zhi; 2007 Nov; 29(11):818-21. PubMed ID: 18396637
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus-mediated p53 gene therapy: overview of preclinical studies and potential clinical applications.
Horowitz J
Curr Opin Mol Ther; 1999 Aug; 1(4):500-9. PubMed ID: 11713766
[TBL] [Abstract][Full Text] [Related]
9. Intra-arterial delivery of p53-containing adenoviral vector into experimental brain tumors.
Abe T; Wakimoto H; Bookstein R; Maneval DC; Chiocca EA; Basilion JP
Cancer Gene Ther; 2002 Mar; 9(3):228-35. PubMed ID: 11896438
[TBL] [Abstract][Full Text] [Related]
10. Effect of p53 gene transfer and cisplatin in a peritonitis carcinomatosa model with p53-deficient ovarian cancer cells.
Kigawa J; Sato S; Shimada M; Kanamori Y; Itamochi H; Terakawa N
Gynecol Oncol; 2002 Feb; 84(2):210-5. PubMed ID: 11812076
[TBL] [Abstract][Full Text] [Related]
11. Biological activities of a recombinant adenovirus p53 (SCH 58500) administered by hepatic arterial infusion in a Phase 1 colorectal cancer trial.
Atencio IA; Grace M; Bordens R; Fritz M; Horowitz JA; Hutchins B; Indelicato S; Jacobs S; Kolz K; Maneval D; Musco ML; Shinoda J; Venook A; Wen S; Warren R
Cancer Gene Ther; 2006 Feb; 13(2):169-81. PubMed ID: 16082381
[TBL] [Abstract][Full Text] [Related]
12. Blockage of HGF/c-Met system by gene therapy (adenovirus-mediated NK4 gene) suppresses hepatocellular carcinoma in mice.
Son G; Hirano T; Seki E; Iimuro Y; Nukiwa T; Matsumoto K; Nakamura T; Fujimoto J
J Hepatol; 2006 Nov; 45(5):688-95. PubMed ID: 16839638
[TBL] [Abstract][Full Text] [Related]
13. High volume hydrodynamic injection of plasmid DNA via the hepatic artery results in a high level of gene expression in rat hepatocellular carcinoma induced by diethylnitrosamine.
Tada M; Hatano E; Taura K; Nitta T; Koizumi N; Ikai I; Shimahara Y
J Gene Med; 2006 Aug; 8(8):1018-26. PubMed ID: 16779866
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus vector-mediated gene transfer using degradable starch microspheres for hepatocellular carcinoma in rats.
Shiba H; Okamoto T; Futagawa Y; Misawa T; Yanaga K; Ohashi T; Eto Y
J Surg Res; 2006 Jun; 133(2):193-6. PubMed ID: 16730258
[TBL] [Abstract][Full Text] [Related]
15. Efficient and cancer-selective gene transfer to hepatocellular carcinoma in a rat using adenovirus vector with iodized oil esters.
Shiba H; Okamoto T; Futagawa Y; Ohashi T; Eto Y
Cancer Gene Ther; 2001 Oct; 8(10):713-8. PubMed ID: 11687894
[TBL] [Abstract][Full Text] [Related]
16. p53 gene therapy in vivo of herpatocellular and liver metastatic colorectal cancer.
Bookstein R; Demers W; Gregory R; Maneval D; Park J; Wills K
Semin Oncol; 1996 Feb; 23(1):66-77. PubMed ID: 8607033
[TBL] [Abstract][Full Text] [Related]
17. Increased efficacy and safety in the treatment of experimental liver cancer with a novel adenovirus-alphavirus hybrid vector.
Guan M; Rodriguez-Madoz JR; Alzuguren P; Gomar C; Kramer MG; Kochanek S; Prieto J; Smerdou C; Qian C
Cancer Res; 2006 Feb; 66(3):1620-9. PubMed ID: 16452221
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy of orthotopic hepatocellular carcinoma in rats using adenovirus coding for interleukin 12.
Barajas M; Mazzolini G; Genové G; Bilbao R; Narvaiza I; Schmitz V; Sangro B; Melero I; Qian C; Prieto J
Hepatology; 2001 Jan; 33(1):52-61. PubMed ID: 11124820
[TBL] [Abstract][Full Text] [Related]
19. Clinical trial of E1B-deleted adenovirus (dl1520) gene therapy for hepatocellular carcinoma.
Habib N; Salama H; Abd El Latif Abu Median A; Isac Anis I; Abd Al Aziz RA; Sarraf C; Mitry R; Havlik R; Seth P; Hartwigsen J; Bhushan R; Nicholls J; Jensen S
Cancer Gene Ther; 2002 Mar; 9(3):254-9. PubMed ID: 11896441
[TBL] [Abstract][Full Text] [Related]
20. A blood-tumor barrier limits gene transfer to experimental liver cancer: the effect of vasoactive compounds.
Bilbao R; Bustos M; Alzuguren P; Pajares MJ; Drozdzik M; Qian C; Prieto J
Gene Ther; 2000 Nov; 7(21):1824-32. PubMed ID: 11110414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
